Literature DB >> 20919929

Process optimization by response surface design and characterization study on geniposide pharmacosomes.

Peng-Fei Yue1, Qin Zheng, Bin Wu, Ming Yang, Mu-Sheng Wang, Hai-Yan Zhang, Peng-Yi Hu, Zhen-Feng Wu.   

Abstract

The objective of this study was to prepare and characterize geniposide-pharmcosomes (GP-PMS) and optimize the process and formulation variables using response surface methodology. Tetrahydrofuran was used as a reaction medium, GP and phospholipids were resolved into the medium, and GP-PMS was formed after the organic solvent was evaporated off under vacuum condition. The process and formulation variables were optimized by central composite design (CCD) of response surface methodology (RSM). The phospholipid-to-drug ratio (X(1)), reaction temperature (X(2)) and the drug concentration (X(3)) were selected as independent variables and the yield (%) of GP 'present as a complex' in the PMS was used as the dependent variable. The physico-chemical properties of the complex obtained by optimal parameters were investigated by means of Fourier transform infrared spectrophotometry (FT-IR), differential scanning calorimetry, n-octanol/water partition coefficient (P) and particle size analysis. Multiple linear regression analysis for optimization by CCD revealed that the higher the yield of GP 'present as a complex' in the GP-PMS was obtained wherein the optimal settings of X(1), X(2) and X(3) are 3, 50°C and 5.5 mg/mL, respectively. The DSC and IR studies of GP-PMS by the optimal settings demonstrated that GP and phospholipids in the GP-PMS were combined by non-covalent bond, not forming a new compound. GP-PMS could significantly increased the lipophilicify of GP, and P of GP-PMS in n-octanol and water was about 20 multiples more than that of GP material. Pharmacosomes could be an alternative approach to improve the absorption and permeation of biologically active constituents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20919929     DOI: 10.3109/10837450.2010.516439

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  4 in total

1.  Geniposide attenuates epilepsy symptoms in a mouse model through the PI3K/Akt/GSK-3β signaling pathway.

Authors:  Hongtao Wei; Guanghui Duan; Jianxun He; Qinglong Meng; Yuxian Liu; Wanqiang Chen; Yongpeng Meng
Journal:  Exp Ther Med       Date:  2017-11-14       Impact factor: 2.447

2.  20(S)-Protopanaxadiol Phospholipid Complex: Process Optimization, Characterization, In Vitro Dissolution and Molecular Docking Studies.

Authors:  Yiqiong Pu; Xitong Zhang; Qi Zhang; Bing Wang; Yuxi Chen; Chuanqi Zang; Yuqin Wang; Tina Ting-Xia Dong; Tong Zhang
Journal:  Molecules       Date:  2016-10-19       Impact factor: 4.411

3.  Process optimization and evaluation of novel baicalin solid nanocrystals.

Authors:  Peng-Fei Yue; Yu Li; Jing Wan; Yong Wang; Ming Yang; Wei-Feng Zhu; Chang-Hong Wang; Hai-Long Yuan
Journal:  Int J Nanomedicine       Date:  2013-08-09

Review 4.  Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs.

Authors:  Archana Pandita; Pooja Sharma
Journal:  ISRN Pharm       Date:  2013-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.